Mankind Pharma Ltd

Mankind Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Mankind Pharma Ltd

₹ 2,257 -0.57%
13 Nov - close price
mankindpharma.com BSE: 543904 NSE: MANKIND
About

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.[1]

Key Points

Leadership[1]
- 1 Rank in Prescriptions over the last 5 yrs.
- Youngest in the Top 5 of the IPM
- 4 By value in the IPM
- 4 Consumer Healthcare brands Market ranked
1 in their categories

Website BSE NSE
  • Market Cap ₹ 93,160 Cr.
  • Current Price ₹ 2,257
  • High / Low ₹ 3,055 / 2,115
  • Stock P/E 53.3
  • Book Value ₹ 370
  • Dividend Yield 0.04 %
  • ROCE 16.0 %
  • ROE 14.7 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Debtor days have increased from 33.4 to 46.0 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare BSE 200 BSE Dollex 200 Nifty 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
2,426 2,091 2,053 2,579 2,708 2,607 2,422 2,868 3,061 3,199 3,079 3,570 3,697
1,835 1,654 1,636 1,924 2,025 2,000 1,836 2,196 2,214 2,383 2,396 2,724 2,776
Operating Profit 591 437 417 655 683 606 586 672 847 816 683 847 921
OPM % 24% 21% 20% 25% 25% 23% 24% 23% 28% 26% 22% 24% 25%
31 40 50 63 63 75 94 108 109 87 249 83 94
Interest 10 13 5 6 9 9 9 11 7 221 191 171 170
Depreciation 79 85 85 87 96 110 100 103 100 187 231 219 222
Profit before tax 533 379 377 624 641 562 572 666 849 495 511 540 624
Tax % 21% 22% 22% 21% 20% 18% 17% 18% 22% 22% 17% 18% 17%
423 296 294 494 511 460 477 543 659 385 425 445 520
EPS in Rs 10.48 7.09 7.13 12.15 12.51 11.33 11.76 13.39 16.31 9.22 10.20 10.62 12.39
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
3,334 5,865 6,214 7,782 8,749 10,260 12,207 13,546
2,748 4,427 4,565 5,791 6,848 7,743 9,182 10,278
Operating Profit 586 1,438 1,649 1,991 1,902 2,517 3,026 3,267
OPM % 18% 25% 27% 26% 22% 25% 25% 24%
76 122 183 210 141 295 548 514
Interest 2 23 21 60 46 34 432 752
Depreciation 39 99 119 167 326 378 621 859
Profit before tax 621 1,438 1,692 1,975 1,671 2,399 2,521 2,171
Tax % 29% 27% 24% 26% 22% 19% 20%
445 1,056 1,293 1,453 1,310 1,942 2,011 1,774
EPS in Rs 219.33 25.72 31.59 35.78 32.00 47.75 48.26 42.43
Dividend Payout % 0% 0% 24% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 14%
5 Years: 16%
3 Years: 16%
TTM: 24%
Compounded Profit Growth
10 Years: 15%
5 Years: 12%
3 Years: 8%
TTM: -17%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -13%
Return on Equity
10 Years: %
5 Years: 20%
3 Years: 18%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 20 40 40 40 40 40 41 41
Reserves 2,035 3,445 4,682 6,115 7,395 9,323 14,291 15,245
0 131 241 873 170 207 8,511 8,369
968 1,449 1,397 2,080 2,080 2,313 4,808 5,159
Total Liabilities 3,022 5,065 6,360 9,108 9,686 11,883 27,652 28,813
316 1,600 1,664 3,588 4,251 4,545 19,005 19,263
CWIP 47 317 372 701 550 282 826 394
Investments 959 829 1,512 1,109 1,346 2,568 2,042 2,947
1,700 2,319 2,811 3,709 3,538 4,488 5,780 6,209
Total Assets 3,022 5,065 6,360 9,108 9,686 11,883 27,652 28,813

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1,070 1,137 920 1,813 2,152 2,413
-436 -1,222 -1,369 -1,052 -2,081 -12,624
-531 -8 605 -740 5 10,233
Net Cash Flow 103 -92 156 22 77 22

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 22 33 19 18 24 30 46
Inventory Days 166 175 243 265 188 180 219
Days Payable 71 145 137 162 126 90 119
Cash Conversion Cycle 117 63 125 121 85 120 146
Working Capital Days 56 30 32 24 39 53 -28
ROCE % 37% 32% 22% 26% 16%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
76.50% 76.50% 76.50% 74.88% 74.87% 74.87% 72.71% 72.70% 72.67% 72.67%
4.18% 4.18% 6.74% 9.87% 11.58% 12.37% 13.34% 12.92% 13.07% 12.83%
4.65% 4.56% 9.78% 11.14% 9.94% 9.91% 11.05% 11.47% 11.50% 11.91%
14.67% 14.76% 6.97% 4.10% 3.61% 2.86% 2.89% 2.89% 2.75% 2.57%
No. of Shareholders 1,31,9181,34,7311,27,4491,35,1161,53,4501,63,8541,71,2811,80,5971,79,5491,70,347

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls